Skip to main content
Erschienen in: Cancer Causes & Control 6/2012

01.06.2012 | Original paper

Socioeconomic disparities and breast cancer hormone receptor status

verfasst von: Abegail A. Andaya, Lindsey Enewold, Marie-Josèphe Horner, Ismail Jatoi, Craig D. Shriver, Kangmin Zhu

Erschienen in: Cancer Causes & Control | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Recent research, although inconsistent, indicates that socioeconomic status (SES) may be associated with hormone receptor (HR) status. This study aims to examine the association between SES and breast cancer HR status within and across racial/ethnic groups stratified by age at diagnosis and tumor stage.

Methods

The study subjects were 184,602 women with incident breast cancer diagnosed during 2004–2007 and identified from the National Cancer Institute’s Surveillance, Epidemiology and End Results program. Log-binomial regression assessed the risk of having breast tumors that were (1) HR-negative versus HR-positive and (2) HR-unknown versus HR-known between women who, at the time of diagnosis, were residing in high or medium poverty areas compared to low poverty areas.

Results

High poverty areas tended to have a greater prevalence of HR-negative tumors compared to more affluent areas. Although not always significant, this was observed among non-Hispanic white and Hispanic women regardless of age-tumor stage category, and only among young, non-Hispanic black women and non-Hispanic Asian/Pacific Islander women with regional and distant stage. High poverty areas also tended to have a greater prevalence of HR-unknown tumors compared to more affluent areas. Furthermore, significant trends between HR status and poverty level varied by race/ethnicity, age, and tumor stage.

Conclusions

Poverty may be related to breast cancer negative and unknown HR status. These findings suggest the effects of non-genetic factors on biochemical features of breast cancer, as well as imply a clinical importance to improve HR measurement or recording for low socioeconomic breast cancer patients.
Literatur
1.
Zurück zum Zitat Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46(12 Suppl):2884–2888PubMedCrossRef Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL (1980) The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46(12 Suppl):2884–2888PubMedCrossRef
2.
Zurück zum Zitat Rastelli F, Crispino S (2008) Factors predictive of response to hormone therapy in breast cancer. Tumori 94(3):370–383PubMed Rastelli F, Crispino S (2008) Factors predictive of response to hormone therapy in breast cancer. Tumori 94(3):370–383PubMed
3.
Zurück zum Zitat Early Breast Cancer Trialists’ Collaborative Group (2001) Tamoxifen for early breast cancer. Cochrane Database Syst Rev 1:CD000486 Early Breast Cancer Trialists’ Collaborative Group (2001) Tamoxifen for early breast cancer. Cochrane Database Syst Rev 1:CD000486
4.
Zurück zum Zitat Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK et al (2005) Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97(17):1254–1261PubMedCrossRef Arpino G, Weiss H, Lee AV, Schiff R, De Placido S, Osborne CK et al (2005) Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. J Natl Cancer Inst 97(17):1254–1261PubMedCrossRef
5.
Zurück zum Zitat Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6PubMedCrossRef Dunnwald LK, Rossing MA, Li CI (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9(1):R6PubMedCrossRef
6.
Zurück zum Zitat Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92(1):37–45PubMedCrossRef Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92(1):37–45PubMedCrossRef
7.
Zurück zum Zitat Stanford JL, Greenberg RS (1989) Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health 79(1):71–73PubMedCrossRef Stanford JL, Greenberg RS (1989) Breast cancer incidence in young women by estrogen receptor status and race. Am J Public Health 79(1):71–73PubMedCrossRef
8.
Zurück zum Zitat Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D et al (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3(2):127–135PubMed Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D et al (1994) Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3(2):127–135PubMed
9.
Zurück zum Zitat Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22(1):55–65PubMedCrossRef Gordon NH (2003) Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22(1):55–65PubMedCrossRef
10.
Zurück zum Zitat Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142(8):796–803PubMed Gordon NH (1995) Association of education and income with estrogen receptor status in primary breast cancer. Am J Epidemiol 142(8):796–803PubMed
11.
Zurück zum Zitat Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19(10):1305–1318PubMedCrossRef Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions. Cancer Causes Control 19(10):1305–1318PubMedCrossRef
12.
Zurück zum Zitat Data: Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat database: incidence—SEER 17 regs research data + Hurricane Katrina impacted Louisiana cases, Nov 2009 Sub (1973–2007 varying)—Linked to county attributes—total U.S., 1969–2007 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission Data: Surveillance, Epidemiology, and End Results (SEER) Program (http://​www.​seer.​cancer.​gov) SEER*Stat database: incidence—SEER 17 regs research data + Hurricane Katrina impacted Louisiana cases, Nov 2009 Sub (1973–2007 varying)—Linked to county attributes—total U.S., 1969–2007 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2010, based on the November 2009 submission
14.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2009) American joint committee on cancer staging manual, 7th edn. Springer, New York, NY Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (eds) (2009) American joint committee on cancer staging manual, 7th edn. Springer, New York, NY
15.
Zurück zum Zitat Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol 156(5):471–482PubMedCrossRef Krieger N, Chen JT, Waterman PD, Soobader MJ, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter? The public health disparities geocoding project. Am J Epidemiol 156(5):471–482PubMedCrossRef
16.
Zurück zum Zitat Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project. Am J Public Health 93(10):1655–1671PubMedCrossRef Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV (2003) Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures—the public health disparities geocoding project. Am J Public Health 93(10):1655–1671PubMedCrossRef
17.
Zurück zum Zitat Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI cancer surveillance monograph series, number 4. National Cancer Institute, Bethesda, MD, NIH Publication No 03–0000. Singh GK, Miller BA, Hankey BF, Edwards BK (2003) Area socioeconomic variations in U.S. Cancer incidence, mortality, stage, treatment, and survival, 1975–1999. NCI cancer surveillance monograph series, number 4. National Cancer Institute, Bethesda, MD, NIH Publication No 03–0000.
19.
Zurück zum Zitat Morabia A, Flandre P (1992) Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21(2):222–228PubMedCrossRef Morabia A, Flandre P (1992) Misclassification bias related to definition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21(2):222–228PubMedCrossRef
20.
Zurück zum Zitat Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162(3):199–200PubMedCrossRef Spiegelman D, Hertzmark E (2005) Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 162(3):199–200PubMedCrossRef
21.
Zurück zum Zitat Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ (2001) Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health 55(5):308–315PubMedCrossRef Thomson CS, Hole DJ, Twelves CJ, Brewster DH, Black RJ (2001) Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival. J Epidemiol Community Health 55(5):308–315PubMedCrossRef
22.
Zurück zum Zitat Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health Larchmt 18(6):883–893PubMedCrossRef Vona-Davis L, Rose DP (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health Larchmt 18(6):883–893PubMedCrossRef
23.
Zurück zum Zitat Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12(10):1053–1060PubMed Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S (2003) Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12(10):1053–1060PubMed
24.
Zurück zum Zitat Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91(4):580–584PubMedCrossRef Manjer J, Malina J, Berglund G, Bondeson L, Garne JP, Janzon L (2001) Smoking associated with hormone receptor negative breast cancer. Int J Cancer 91(4):580–584PubMedCrossRef
25.
Zurück zum Zitat Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 59(1):119–125PubMedCrossRef Cooper JA, Rohan TE, Cant EL, Horsfall DJ, Tilley WD (1989) Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. Br J Cancer 59(1):119–125PubMedCrossRef
26.
Zurück zum Zitat Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 79(7–8):1308–1314PubMedCrossRef Enger SM, Ross RK, Paganini-Hill A, Longnecker MP, Bernstein L (1999) Alcohol consumption and breast cancer oestrogen and progesterone receptor status. Br J Cancer 79(7–8):1308–1314PubMedCrossRef
27.
Zurück zum Zitat Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL et al (2007) Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 167(4):408–415PubMedCrossRef Dallal CM, Sullivan-Halley J, Ross RK, Wang Y, Deapen D, Horn-Ross PL et al (2007) Long-term recreational physical activity and risk of invasive and in situ breast cancer: the California teachers study. Arch Intern Med 167(4):408–415PubMedCrossRef
28.
Zurück zum Zitat Peters TM, Schatzkin A, Gierach GL, Moore SC, Lacey JV Jr, Wareham NJ et al (2009) Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 18(1):289–296PubMedCrossRef Peters TM, Schatzkin A, Gierach GL, Moore SC, Lacey JV Jr, Wareham NJ et al (2009) Physical activity and postmenopausal breast cancer risk in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev 18(1):289–296PubMedCrossRef
29.
Zurück zum Zitat Park Y, Brinton LA, Subar AF, Hollenbeck A, Schatzkin A (2009) Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 90(3):664–671PubMedCrossRef Park Y, Brinton LA, Subar AF, Hollenbeck A, Schatzkin A (2009) Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 90(3):664–671PubMedCrossRef
30.
Zurück zum Zitat Champagne CM, Bogle ML, McGee BB, Yadrick K, Allen HR, Kramer TR et al (2004) Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J Am Diet Assoc 104(2):199–207PubMedCrossRef Champagne CM, Bogle ML, McGee BB, Yadrick K, Allen HR, Kramer TR et al (2004) Dietary intake in the lower Mississippi delta region: results from the Foods of our Delta Study. J Am Diet Assoc 104(2):199–207PubMedCrossRef
31.
Zurück zum Zitat Turrell G, Hewitt B, Patterson C, Oldenburg B, Gould T (2002) Socioeconomic differences in food purchasing behaviour and suggested implications for diet-related health promotion. J Hum Nutr Diet 15(5):355–364PubMedCrossRef Turrell G, Hewitt B, Patterson C, Oldenburg B, Gould T (2002) Socioeconomic differences in food purchasing behaviour and suggested implications for diet-related health promotion. J Hum Nutr Diet 15(5):355–364PubMedCrossRef
32.
Zurück zum Zitat Bennett GG, McNeill LH, Wolin KY, Duncan DT, Puleo E, Emmons KM (2007) Safe to walk? Neighborhood safety and physical activity among public housing residents. PLoS Med 4(10):1599–1606; discussion 1607 Bennett GG, McNeill LH, Wolin KY, Duncan DT, Puleo E, Emmons KM (2007) Safe to walk? Neighborhood safety and physical activity among public housing residents. PLoS Med 4(10):1599–1606; discussion 1607
33.
Zurück zum Zitat Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690PubMedCrossRef Jatoi I, Chen BE, Anderson WF, Rosenberg PS (2007) Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis. J Clin Oncol 25(13):1683–1690PubMedCrossRef
34.
Zurück zum Zitat Narod SA, Dube MP (2001) Re: biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 93(2):151–152PubMed Narod SA, Dube MP (2001) Re: biologic characteristics of interval and screen-detected breast cancers. J Natl Cancer Inst 93(2):151–152PubMed
35.
Zurück zum Zitat Anderson WF, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943–2002). Breast Cancer Res Treat 99(3):333–340PubMedCrossRef Anderson WF, Jatoi I, Devesa SS (2006) Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943–2002). Breast Cancer Res Treat 99(3):333–340PubMedCrossRef
36.
Zurück zum Zitat Porta M, Bosch de Basea M, Benavides FG, Lopez T, Fernandez E, Marco E et al (2008) Differences in serum concentrations of organochlorine compounds by occupational social class in pancreatic cancer. Environ Res 108(3):370–379PubMedCrossRef Porta M, Bosch de Basea M, Benavides FG, Lopez T, Fernandez E, Marco E et al (2008) Differences in serum concentrations of organochlorine compounds by occupational social class in pancreatic cancer. Environ Res 108(3):370–379PubMedCrossRef
37.
Zurück zum Zitat Sexton K, Adgate JL, Fredrickson AL, Ryan AD, Needham LL, Ashley DL (2006) Using biologic markers in blood to assess exposure to multiple environmental chemicals for inner-city children 3-6 years of age. Environ Health Perspect 114(3):453–459PubMedCrossRef Sexton K, Adgate JL, Fredrickson AL, Ryan AD, Needham LL, Ashley DL (2006) Using biologic markers in blood to assess exposure to multiple environmental chemicals for inner-city children 3-6 years of age. Environ Health Perspect 114(3):453–459PubMedCrossRef
38.
Zurück zum Zitat Hoyer AP, Jorgensen T, Rank F, Grandjean P (2001) Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer 1:8PubMedCrossRef Hoyer AP, Jorgensen T, Rank F, Grandjean P (2001) Organochlorine exposures influence on breast cancer risk and survival according to estrogen receptor status: a Danish cohort-nested case-control study. BMC Cancer 1:8PubMedCrossRef
39.
Zurück zum Zitat Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE et al (2001) Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12(5):395–404PubMedCrossRef Woolcott CG, Aronson KJ, Hanna WM, SenGupta SK, McCready DR, Sterns EE et al (2001) Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12(5):395–404PubMedCrossRef
40.
Zurück zum Zitat Haggstrom DA, Quale C, Smith-Bindman R (2005) Differences in the quality of breast cancer care among vulnerable populations. Cancer 104(11):2347–2358PubMedCrossRef Haggstrom DA, Quale C, Smith-Bindman R (2005) Differences in the quality of breast cancer care among vulnerable populations. Cancer 104(11):2347–2358PubMedCrossRef
Metadaten
Titel
Socioeconomic disparities and breast cancer hormone receptor status
verfasst von
Abegail A. Andaya
Lindsey Enewold
Marie-Josèphe Horner
Ismail Jatoi
Craig D. Shriver
Kangmin Zhu
Publikationsdatum
01.06.2012
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 6/2012
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-9966-1

Weitere Artikel der Ausgabe 6/2012

Cancer Causes & Control 6/2012 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.